Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IPHA Innate Pharma SA

未开盘 11-18 16:00:00 EST

1.53

+0.09

+6.25%

最高1.66	最低1.29	成交量4.16万
今开1.45	昨收1.44	日振幅25.76%
总市值1.24亿	流通市值4,829万	总股本8,095万
成交额6.00万	换手率0.13%	流通股本3,156万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IPHA","market":"US","secType":"STK","nameCN":"Innate Pharma SA","latestPrice":1.53,"timestamp":1731963600000,"preClose":1.44,"halted":0,"volume":41648,"delay":0,"floatShares":31561009,"shares":80950782,"eps":-0.451948,"marketStatus":"未开盘","marketStatusCode":0,"change":0.09,"latestTime":"11-18 16:00:00 EST","open":1.45,"high":1.661,"low":1.29,"amount":60026.654339,"amplitude":0.257639,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.451948,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":1571284800000,"adjPreClose":1.44,"adrRate":1,"volumeRatio":4.489382},"requestUrl":"/m/hq/s/IPHA","defaultTab":"news","newsList":[{"id":"2483704413","title":"Innate Pharma盘中异动 早盘股价大跌6.61%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483704413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483704413?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:06","pubTimestamp":1731683165,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时06分，Innate Pharma股票出现异动，股价急速下挫6.61%。截至发稿，该股报1.56美元/股，成交量5568股，换手率0.01%，振幅0.60%。Innate Pharma股票所在的生物技术行业中，整体跌幅为2.65%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115230605971a6ded&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115230605971a6ded&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0},{"id":"2483839940","title":"Innate Pharma股价重挫10.53% 市值跌1449.1万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483839940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483839940?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:37","pubTimestamp":1731515820,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时37分，Innate Pharma股票出现波动，股价急速下跌10.53%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Syros Pharmaceuticals, Inc.较为活跃，换手率分别为483.22%、288.36%、104.92%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Calidi Biotherapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为88.00%、67.77%、46.01%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111400370095be24e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111400370095be24e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"gpt_icon":0},{"id":"2482736907","title":"Innate Pharma盘中异动 早盘股价大跌8.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482736907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482736907?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:07","pubTimestamp":1731337629,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时07分，Innate Pharma股票出现波动，股价急速跳水8.74%。截至发稿，该股报1.68美元/股，成交量116股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.03%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111230709971a5bd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111230709971a5bd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"gpt_icon":0},{"id":"2481110145","title":"Innate Pharma盘中异动 早盘股价大跌14.89%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481110145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481110145?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076346,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分，Innate Pharma股票出现异动，股价快速跳水14.89%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Fortrea Holdings Inc.、Tenaya Therapeutics, Inc.、Rigel Pharmaceuticals, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为381.59%、16.43%、13.96%，振幅较大的相关个股有Anebulo Pharmaceuticals, Inc.、Cardiff Oncology, Inc.、Rigel Pharmaceuticals, Inc.，振幅分别为14.96%、14.91%、14.90%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822322795bdef18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822322795bdef18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0},{"id":"2481663649","title":"Innate Pharma盘中异动 股价大跌5.32%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481663649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481663649?lang=zh_cn&edition=full","pubTime":"2024-11-06 01:54","pubTimestamp":1730829241,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日01时54分，Innate Pharma股票出现波动，股价快速跳水5.32%。截至发稿，该股报1.73美元/股，成交量1130股，换手率0.00%，振幅0.00%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。Innate Pharma股票所在的生物技术行业中，整体涨幅为1.45%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110601540195bdd3b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110601540195bdd3b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"gpt_icon":0},{"id":"2478435895","title":"Innate Pharma盘中异动 快速下挫5.00%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478435895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478435895?lang=zh_cn&edition=full","pubTime":"2024-10-28 23:02","pubTimestamp":1730127750,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日23时02分，Innate Pharma股票出现异动，股价快速跳水5.00%。截至发稿，该股报1.71美元/股，成交量8591股，换手率0.01%，振幅2.78%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.43%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028230230a1f27c91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028230230a1f27c91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","BK4139","IPHYF"],"gpt_icon":0},{"id":"2477456385","title":"Innate Pharma盘中异动 下午盘大幅下跌6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477456385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477456385?lang=zh_cn&edition=full","pubTime":"2024-10-24 02:50","pubTimestamp":1729709459,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日02时50分，Innate Pharma股票出现波动，股价急速下挫6.42%。Innate Pharma股票所在的生物技术行业中，整体跌幅为1.58%。其相关个股中，Virax Biolabs Group Limited、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tevogen Bio Holdings Inc.涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1909.46%、1573.31%、515.82%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.，振幅分别为109.26%、108.42%、68.32%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102402505998e3e0f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102402505998e3e0f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0},{"id":"2477866997","title":"Innate Pharma盘中异动 急速下挫5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477866997","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477866997?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:01","pubTimestamp":1729519287,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时01分，Innate Pharma股票出现异动，股价急速下跌5.65%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Biovie Inc.、Gri Bio, Inc.、Genprex, Inc.涨幅较大，Gri Bio, Inc.、Genprex, Inc.、Biovie Inc.较为活跃，换手率分别为2294.32%、2066.68%、677.86%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ，振幅分别为176.03%、154.89%、116.08%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021220128ab6bb91e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021220128ab6bb91e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0},{"id":"2476717302","title":"Innate Pharma盘中异动 大幅跳水5.24%报1.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476717302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476717302?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:02","pubTimestamp":1729173760,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时02分，Innate Pharma股票出现波动，股价快速下挫5.24%。截至发稿，该股报1.99美元/股，成交量5240股，换手率0.01%，振幅0.48%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.85%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101722024098e3d04a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101722024098e3d04a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0},{"id":"2475939924","title":"Innate Pharma盘中异动 临近午盘股价大跌6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475939924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475939924?lang=zh_cn&edition=full","pubTime":"2024-10-14 23:30","pubTimestamp":1728919803,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日23时30分，Innate Pharma股票出现波动，股价急速下跌6.28%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.81%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Aditxt, Inc.、Rani Therapeutics Holdings, Inc.、Tevogen Bio Holdings Inc.较为活跃，换手率分别为214.71%、121.62%、108.55%，振幅较大的相关个股有Tevogen Bio Holdings Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为149.47%、119.48%、119.46%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014233003971a024c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014233003971a024c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA"],"gpt_icon":0},{"id":"2474724570","title":"Innate Pharma盘中异动 下午盘急速下跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474724570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474724570?lang=zh_cn&edition=full","pubTime":"2024-10-11 01:05","pubTimestamp":1728579901,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日01时05分，Innate Pharma股票出现异动，股价快速下挫5.46%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Seastar Medical Holding Corp C/Wts 28/10/2027 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为438.44%、187.84%、111.10%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corp C/Wts 28/10/2027 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为106.67%、66.67%、50.50%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011010502a1dfbd98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011010502a1dfbd98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"gpt_icon":0},{"id":"2472528119","title":"Innate Pharma盘中异动 早盘股价大跌7.49%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472528119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472528119?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:31","pubTimestamp":1728048677,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时31分，Innate Pharma股票出现波动，股价快速下挫7.49%。截至发稿，该股报2.10美元/股，成交量544股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.12%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004213117958fae86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004213117958fae86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"gpt_icon":0},{"id":"2472300717","title":"Innate Pharma盘中异动 下午盘大幅下挫5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472300717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472300717?lang=zh_cn&edition=full","pubTime":"2024-10-02 01:56","pubTimestamp":1727805371,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日01时56分，Innate Pharma股票出现波动，股价大幅下挫5.19%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.08%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100201561298e3a049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100201561298e3a049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0},{"id":"2468577287","title":"Innate Pharma盘中异动 早盘股价大跌6.22%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468577287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468577287?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:39","pubTimestamp":1726753141,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时39分，Innate Pharma股票出现波动，股价急速下挫6.22%。截至发稿，该股报2.11美元/股，成交量3313股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.91%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192139019f07f466&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192139019f07f466&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0},{"id":"2460066755","title":"Innate Pharma盘中异动 快速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460066755","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460066755?lang=zh_cn&edition=full","pubTime":"2024-08-20 03:41","pubTimestamp":1724096479,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日03时41分，Innate Pharma股票出现异动，股价快速拉升5.42%。Innate Pharma股票所在的生物技术行业中，整体涨幅为1.03%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Nucana Plc涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为9448.91%、3901.38%、1335.63%，振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为456.88%、220.18%、198.02%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408200341209719931a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408200341209719931a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0},{"id":"2459473293","title":"Innate Pharma盘中异动 股价大跌6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459473293","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459473293?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:11","pubTimestamp":1723731062,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时11分，Innate Pharma股票出现异动，股价快速下挫6.03%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Cingulate Inc.、Scisparc Ltd.、Tempest Therapeutics, Inc.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为5206.93%、1892.50%、418.74%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Cingulate Inc.、Tempest Therapeutics, Inc.，振幅分别为103.98%、58.54%、51.18%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408152211029f2e0fe9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408152211029f2e0fe9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","BK4139","IPHYF"],"gpt_icon":0},{"id":"2459848056","title":"Innate Pharma盘中异动 临近收盘股价大涨7.91%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459848056","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459848056?lang=zh_cn&edition=full","pubTime":"2024-08-15 03:57","pubTimestamp":1723665435,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日03时57分，Innate Pharma股票出现波动，股价急速上涨7.91%。截至发稿，该股报2.32美元/股，成交量2540股，换手率0.00%，振幅0.93%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.10%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815035716ab5db235&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815035716ab5db235&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0},{"id":"2458987771","title":"Innate Pharma盘中异动 早盘股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458987771","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458987771?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:50","pubTimestamp":1723474201,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时50分，Innate Pharma股票出现异动，股价急速下挫5.31%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Revance Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、60 Degrees Pharmaceuticals, Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、Revance Therapeutics, Inc.较为活跃，换手率分别为529.47%、69.86%、40.80%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为91.10%、40.71%、39.83%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122250019592b746&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122250019592b746&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"gpt_icon":0},{"id":"2458213329","title":"Innate Pharma盘中异动 股价大涨6.05%报2.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458213329","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458213329?lang=zh_cn&edition=full","pubTime":"2024-08-09 03:47","pubTimestamp":1723146472,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日03时47分，Innate Pharma股票出现异动，股价快速拉升6.05%。截至发稿，该股报2.26美元/股，成交量441股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为3.60%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809034752968253d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809034752968253d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"gpt_icon":0},{"id":"2457008988","title":"Innate Pharma盘中异动 股价大涨8.47%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457008988","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457008988?lang=zh_cn&edition=full","pubTime":"2024-08-07 03:06","pubTimestamp":1722971167,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日03时06分，Innate Pharma股票出现波动，股价快速上涨8.47%。截至发稿，该股报2.25美元/股，成交量6654股，换手率0.01%，振幅3.38%。Innate Pharma股票所在的生物技术行业中，整体涨幅为1.66%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807030607968246c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807030607968246c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.innate-pharma.com/fr","stockEarnings":[{"period":"1week","weight":-0.173},{"period":"1month","weight":-0.2482},{"period":"3month","weight":-0.3462},{"period":"6month","weight":-0.49},{"period":"1year","weight":-0.3755},{"period":"ytd","weight":-0.4536}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Innate Pharma S.A.成立于1999年9月23日，是一家生物技术公司，致力于发现，开发和商业化一流的治疗性抗体，这些抗体旨在利用免疫系统来治疗严重未满足医疗需求的肿瘤适应症。该公司在免疫肿瘤学的研究和开发方面拥有丰富的经验，是了解自然杀伤细胞或NK细胞生物学的先驱。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.039613},{"month":2,"riseRate":0.2,"avgChangeRate":-0.05047},{"month":3,"riseRate":0.4,"avgChangeRate":0.011353},{"month":4,"riseRate":0.4,"avgChangeRate":-0.037436},{"month":5,"riseRate":0.2,"avgChangeRate":-0.022596},{"month":6,"riseRate":0.6,"avgChangeRate":-0.067147},{"month":7,"riseRate":0.6,"avgChangeRate":0.02867},{"month":8,"riseRate":0.6,"avgChangeRate":0.003211},{"month":9,"riseRate":0.2,"avgChangeRate":-0.014742},{"month":10,"riseRate":0.4,"avgChangeRate":-0.007938},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.015228},{"month":12,"riseRate":0.6,"avgChangeRate":0.122297}],"exchange":"NASDAQ","name":"Innate Pharma SA","nameEN":"Innate Pharma SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Innate Pharma SA(IPHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Innate Pharma SA,IPHA,Innate Pharma SA股票,Innate Pharma SA股票老虎,Innate Pharma SA股票老虎国际,Innate Pharma SA行情,Innate Pharma SA股票行情,Innate Pharma SA股价,Innate Pharma SA股市,Innate Pharma SA股票价格,Innate Pharma SA股票交易,Innate Pharma SA股票购买,Innate Pharma SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Innate Pharma SA(IPHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}